|
KMID : 0986720180260020071
|
|
Korean Journal of Medicine and Law
2018 Volume.26 No. 2 p.71 ~ p.96
|
|
|
International Regulatory Trends on Genome Editing Research Using Human Embryo and Its Implication
|
|
Lee Su-Bin
Kim Han-Nah
|
|
|
Abstract
|
|
|
|
This article explores the regulatory trend of genome editing research using human embryo in overseas countries. The research shows that Malaysia, Singapore, the United Kingdom, India, Japan, China, Canada, and France have legislation or guidelines related to genome editing research using human embryo. Among them, Singapore, the United Kingdom, India, Japan, and China which allow genome editing research using human embryo for limited research purposes, also prohibit genome editing for clinical research purposes. In particular, Singapore, the United Kingdom, and Japan prohibit intrauterine implantation of embryos using genome editing techniques. Meanwhile, Germany, Canada, and France ban genome editing research using human embryo. and the United States allows research through the approval of private institutions. On the other hand, South Korea still does not explicitly regulate genome editing research using human embryo in any direction under the Bioethics and Safety Act. Genome editing research using human embryo is controversial in terms of morality, ethics and science, but we expect the possibility of eradicating diseases, a long-standing human problem, and we need ongoing discussions and research to use and regulate them wisely.
|
|
|
KEYWORD
|
|
|
Gene therapy, Genome editing, CRISPR-Cas9, Human Embryo, Bioethics and Safety Act
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|